alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › panel

panel

5 studies tagged panel, dated 2018-03-20 to 2024-11-22. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Benchmarking of a multi-biomarker low-volume panel for Alzheimer's disease and related dementia research 2024-11-22
  2. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease 2021-02-24
  3. CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls 2019-11-18

Studies

5 studies carry this tag.

Date range

2018 to 2024

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Alzheimer's research & therapy 1
  • Molecular neurobiology 1
  • Movement disorders : official journal of the Movement Disorder Society 1
  • Progress in neurobiology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Benchmarking of a multi-biomarker low-volume panel for Alzheimer's disease and related dementia research

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-11-22 Biomarkers

    The NULISA multiplexed platform produces reliable results for established biomarkers in CSF that are useful in research settings, with the advantage of measuring additional biomarkers using minimal sample volume.

  2. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Molecular neurobiology 2021-02-24 Biomarkers

    Alzheimer's disease (AD) is the most common neurodegenerative disease in the older adults.

  3. CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Movement disorders : official journal of the Movement Disorder Society 2019-11-18 Biomarkers

    CSF neurofilament contributes to a panel of CSF α-synuclein species in differentiating PD patients from healthy controls.

  4. Prognostic plasma protein panel for Aβ deposition in the brain in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Progress in neurobiology 2019-10-09 Biomarkers

    Alzheimer's disease (AD) is the most common age-associated dementia.

  5. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Alzheimer's research & therapy 2018-03-20 Biomarkers

    There were significant global differences in Aβ1-42, T-tau, T-tau/Aβ1-42 ratio, P-tau-181, NFL, AβX-42, AβX-42/X-40 ratio, APPα, and APPβ between groups.

All topic tags with their study counts